Eukarÿs wins the Corporate LiveWire Award for Innovation & Excellence 2020n
August 13, 2020
Eukarÿs winner of the Gene Therapy Challenge of the Startups Meet Pharma 2020 Competition
June 14, 2020
Covid-19, H1N1 influenza, SARS-COV-1, Dengue, Zika, Ebola…: Eukarÿs announces the SHIELD evaluation study for Synthetic Gene Vaccination
March 30, 2020
Covid-19: Eukarÿs makes its C3P3 system available to the scientific community to accelerate the fight against SARS-CoV-2
March 28, 2020
Eukarÿs semi-finalist of the Merck-Millipore’s European Advance Biotech Competition
March 14, 2020
Guillaume Prunier appointed Special Advisor to the President
March 12, 2020
Eukarÿs is nominated at the EIT Health Summit 2019
November 29, 2019
EUK-LPR: Eukarÿs confirms excellent preclinical performance of its first synthetic gene therapy
November 14, 2019
Eukarÿs wins the Galien MedStartUp 2019 Award
October 29, 2019
Galien MedStartup Award: Eukarÿs nominated among the three finalists
October 18, 2019
According to the Journal Insightscare, Eukarÿs is one of The 10 Most Innovative Companies In Gene Therapy
September 09, 2019
Eukarÿs to showcase C3P3 technology and bioproduction applications at PEGS Europe Conference
June 24, 2019
Eukarÿs reaches the final of the RESI Innovation Challenge 2019
March 3, 2019
Eukarÿs publishes the construction process of C3P3-G1, the prototype of the C3P3 artificial expression system
February 6, 2019
Eukarÿs announces the finalization of the 3rd generation of its C3P3 expression system
January 15, 2019
Eukarÿs SAS and PPRS Research Announce Capital and Strategic Partnership
November 21, 2018